Carlos Camacho-Macorra1,2†
Noemí Tabanera1,2
Elena Sánchez-Bustamante1,2
Paola Bovolenta1,2*‡Marcos J. Cardozo1,2‡- 1Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas-Universidad Autónoma de Madrid, Madrid, Spain
- 2Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Madrid, Spain
Gastrulation in zebrafish embryos commences with the morphogenetic rearrangement of blastodermal cells, which undergo a coordinated spreading from the animal pole to wrap around the egg at the vegetal pole. This rearrangement, known as epiboly, relies on the orchestrated activity of maternal transcripts present in the egg, compensating for the gradual activation of the zygotic genome. Epiboly involves the mechano-transducer activity of yap1 but what are the regulators of yap1 activity and whether these are maternally or zygotically derived remain elusive. Our study reveals the crucial role of maternal vgll4a, a proposed Yap1 competitor, during zebrafish epiboly. In embryos lacking maternal/zygotic vgll4a (MZvgll4a), the progression of epiboly and blastopore closure is delayed. This delay is associated with the ruffled appearance of the sliding epithelial cells, decreased expression of yap1-downstream targets and transient impairment of the actomyosin ring at the syncytial layer. Our study also shows that, rather than competing with yap1, vgll4a modulates the levels of the E-cadherin/β-catenin adhesion complex at the blastomeres’ plasma membrane and hence their actin cortex distribution. Taking these results together, we propose that maternal vgll4a acts at epiboly initiation upstream of yap1 and the E-cadherin/β-catenin adhesion complex, contributing to a proper balance between tissue tension/cohesion and contractility, thereby promoting a timely epiboly progression.
Introduction
The three-dimensional organization of multicellular organisms requires morphogenetic tissue rearrangements, which are particularly evident during embryonic development or in pathological conditions, such as wound healing or cancer. These rearrangements are largely coordinated by the interplay among cell-cell interaction, mechanical forces, and signaling pathways, derived, in part, from the surrounding environment. The adaptive morphogenetic outcome critically depends on how the cells integrate and interpret this signal complexity and transmit the message to their nuclei, eliciting a consequent transcriptional response (Wozniak and Chen, 2009).
In several organisms, including the teleost zebrafish, epiboly is the first morphogenetic rearrangement of the gastrulating embryo (Warga and Kimmel, 1990). These cellular rearrangements are relatively simple and thus have been used to understand basic principles of morphogenesis (Kimmel et al., 1995; Bruce, 2016). The zebrafish blastoderm, positioned at the animal pole, is formed by a single layer of loosely packed cells, known as deep cell layer (DEL), which is covered by the so called epithelial enveloping layer (EVL). The blastoderm interfaces with the yolk syncytial layer (YSL), itself a derivative of the blastoderm marginal cells. During epiboly, the blastoderm thins and moves towards the vegetal pole together with the external YSL (E-YSL). These epithelial spreading and thinning are driven, in part, by a circumferential actomyosin network formed by the E-YSL at its border with the EVL. The contraction of this actomyosin ring pulls the EVL to surround the yolk, further dragging the DEL toward the vegetal pole. This process culminates at the end of gastrulation with “blastopore closure” when the blastoderm seals around the yolk (Kimmel et al., 1995; Bruce, 2016).
In zebrafish, gastrulation commences during maternal-to-zygotic transition, a pivotal process marked by the activation of the zygotic genome but with a substantial involvement of maternal transcripts/proteins that endure throughout gastrulation, actively participating in its morphogenesis (Solnica-Krezel, 2020). Several studies have shown that teleost epiboly involves the function of the transcriptional co-activator Yes1 Associated Transcriptional Regulator (Yap1) and of the highly related TAZ (Gee et al., 2011; Hu et al., 2013; Porazinski et al., 2015; Vázquez-Marín et al., 2019). Yap1 was first described as a downstream nuclear effector of the Hippo signaling pathway, which is involved in the control of cell proliferation (Zhao et al., 2007). However, there is evidence that Yap1 can operate, perhaps independently of Hippo signaling, as a mechano-transducer that links mechanical forces to cellular response (Dupont et al., 2011). Cells constantly probe the forces generated in their extracellular environment through plasma membrane adhesive proteins and internal tension adjustments executed by modifications of their actomyosin network. Upon increasing intracellular tension, Yap1, which is normally retained in the cytoplasm, translocates to the nucleus, where it binds to TEA domain (TEAD)-containing transcription factors (TEAD1–TEAD4). The derived complex activates the transcription of target genes, which include F-acting regulators and cell adhesion components, thereby promoting a positive feedback loop that enables cells to counterbalance the external mechanical forces to which they are exposed (Panciera et al., 2017). Consistent with such mechano-transducer activity, yap1 has been shown to regulate medaka fish epiboly progression by controlling the expression of arhgap18, a gene encoding a Rho GTPase activating protein involved in the contraction of the actomyosin ring at the E-YSL/EVL interface (Porazinski et al., 2015). How yap1 activity is controlled and whether this is exerted by maternally or zygotically derived factors remained unanswered.
Vestigial-like protein 4 (Vgll4) is a transcriptional cofactor that can bind directly to TEAD proteins, via its tandem Tondu domain (TDU), thereby competing for the Yap-TEAD interaction and thus mechanistically acting as an inhibitor of Yap activity (Koontz et al., 2013; Jiao et al., 2014; Zhang et al., 2014; Li et al., 2023). In Xenopus and zebrafish the transcripts of the different vgll4 paralogs show a dynamic developmental expression pattern in different tissues (Faucheux et al., 2010; Barrionuevo et al., 2014; Xue et al., 2018) and in zebrafish the mRNA of two (Xue et al., 2018) (vgll4a; vgll4b) of the three paralogs (vgll4a, vgll4b and vgll4l) have been detected at the 1 cell stage (Xue et al., 2018), suggesting a possible early function. Although there are additional and species-specific phenotypes that involve later developing organs (Fillatre et al., 2019; Xue et al., 2019; Wang et al., 2020), loss of function studies in mice and analysis of genetic variants in the teleost Scatophagus argus suggest that Vgll4 participates in the regulation of body size (Feng et al., 2019; Suo et al., 2020; Yang et al., 2020; Sheldon et al., 2022), a trait that is often altered as the consequence of an abnormal gastrulation.
By generating mutants for the three vgll4 paralogs in zebrafish, here we have explored if vgll4 could be involved in controlling yap1 activity during epiboly. We show that maternal but not zygotic vgll4a is required to sustain yap1 signaling and E-cadherin/β-catenin adhesion complex, thereby promoting cell cortex configuration and actomyosin contraction, which drive epiboly progression and, ultimately, an appropriate elongation of the embryonic antero-posterior axis.
Results
vgll4a function is required for proper epiboly progression
To determine whether vgll4 paralogues contribute to zebrafish epiboly, we generated zebrafish lines in which vgll4a, vgll4b and vgll4l genes were mutated using CRISPR-Cas9 technology (Supplementary Figure S1A). Founders carrying frame-shift mutations for either one of the three vgll4 paralogs were selected in the F1 generation, in order to obtain loss of function lines for each one of the existing Vgll4 proteins (Supplementary Figure S1B). Homozygous mutants for vgll4a, vgll4b and vgll4l genes were obtained in F3. Their offspring were viable with no evident developmental phenotypes (Supplementary Figure S1C and data not shown). Similar results were obtained when adult vgll4a;vgll4b double mutants were analyzed (Supplementary Figure S1C).
vgll4a and vgll4b but not vgll4l transcripts are maternally expressed (Xue et al., 2018). We thus searched a possible phenotype in the F4 generation, in which vgll4a or vgll4b parental contribution will be no longer active. By intercrossing adults F3 vgll4a, vgll4b, vgll4l and vgll4a;vgll4b double mutant, we generated F4 embryos lacking both maternal and zygotic contribution of vgll4a (MZvgll4a), vgll4b (MZvgll4b), vgll4l (MZvgll4l) and vgll4a;vgll4b (MZvgll4a;MZvgll4b). The fertilization rate of the obtained heterozygous Mvgll4a and Mvgll4b embryos was significantly lower than in wild type (wt) and heterozygous vgll4a or vgll4b embryos (Supplementary Figures S2A-C). In contrast, the fertilization rate of Mvgll4l heterozygous was similar to that of wt and heterozygous vgll4l embryos (Supplementary Figure S2D). This observation suggests that maternal contribution of both vgll4a and vgll4b could be important for oogenesis.
Despite the decrease in the fertilization rate, viable MZvgll4a embryos appeared to develop normally at least until the 64-cells’ stage (wt, n = 21; MZvgll4a, n = 20 embryos). However, once epiboly begun, their development progressed at a slower pace than in wt embryos (Figure 1A). MZvgll4a;MZvgll4b double mutants were no different from MZvgll4a embryos (Figure 1A), indicating that either maternal vgll4b does not contribute to this process or that both paralogs are involved. Comparison of the position of tbxta-positive margin cells in wt and MZvgll4a embryos confirmed the beginning and extent of this delay in the mutants (Figures 1B–F), that culminated with a considerable delay in their blastopore closure (Figures 1A, G). This support the idea that vgll4a function contributes to epiboly progression.
FIGURE 1. Epiboly progression in MZvgll4a embryos is delayed. (A) Bright field images of wt, MZvgll4a and MZvgll4a;MZvgll4b embryos at different developmental stages as indicated in the panels for wt embryos. Note the delayed epiboly (red brackets) and blastopore closure (red asterisks) as well as the increased distance between the EVL and DEL margins (yellow arrows) in MZvgll4a and MZvgll4a;MZvgll4b embryos as compared to wt. Blastopore closure (red arrow) in mutants occurs when wt embryos have initiated somitogenesis (red dotted line). At the 26 somites’ stage, the tail of mutants is still not fully elongated (red arrowheads). (B–E) Margin cells in wt (B,C) and MZvgll4a (D,E) embryos stained by in situ hybridization of tbtxa at 4.5hpf (B,D) and 8hpf (C,E). (F) Quantification of epiboly progression of wt and MZvgll4a embryos stained by in situ hybridization of tbtxa at 4.5hpf and 8hpf. T-test, p < 0.0001. (G) Quantification of wt and MZvgll4a embryos that do not reach blastopore closure at 10hpf. Fisher’s exact test, p < 0.0001.
The function of vgll4a and vgll4b is required for larval body lengthening
A previous report suggests a relationship between epiboly delay and reduced larvae body size although the precise relationship between the two events has not been fully elucidated (Sun et al., 2017). We thus compared the antero-posterior (A-P) axial length of wt and MZvgll4a larvae at 3dpf, finding a shorter body length in the mutants as compared to the wt (Figures 2A, B). A similar reduced A-P growth was also observed in MZvgll4b and MZvgll4a;MZvgll4b 3dpf larvae but not in the MZvgll4l ones, which presented a size comparable to that of wt (Figure 2B). Notably, complete vgll4 inactivation in the triple MZvgll4a;MZvgll4b;MZvgll4l mutants, was also followed by a considerably shorter A-P size of the mutant larvae at 3dpf (Figure 2C), ruling out effects derived by possible transcriptional compensations among vgll4 paralogs (Sztal and Stainier, 2020).
FIGURE 2. Body length is affected in MZvgll4 larvae which could be related to epiboly progression delay. (A) Lateral views of wt and MZvgll4a larvae at 3dpf (left) and graph (B) showing the quantification of the body length from wt, MZvgll4a, MZvgll4b, MZvgll4l and MZvgll4a;MZvgll4b larvae at 3dpf. Note that MZvgll4a, MZvgll4b and MZvgll4a;MZvgll4b but not MZvgll4l mutants are shorter that the wt. Mann Whitney test, p < 0.0001. (C) The body length of MZvgll4a;MZvgll4b;MZvgll4l triple mutant larvae are also shorter than wt at 3dpf. Kruskal–Wallis test, p < 0.0001. (D) Schematic representation of the experimental design in (F). (E) The blebbistatin treatment at 4hpf during 30 min, delays epiboly progression in wt embryos (F) The treatment of wt embryos with blebbistatin at 4hpf during 30 min affects the body length of the larvae at 3dpf. Mann Whitney test, p < 0.0001. But not at 3hpf nor 5 hpf. Mann Whitney test, p = 0.2545 and p = 0.4396 respectively. T-test, p < 0.0001. Ns, not significant. ****p < 0.0001.
To provide evidence that the reduced body size of MZvgll4a larvae is linked to a delay in epiboly progression, we pharmacologically interfered with this process by treating wt embryos with blebbistatin (50 μM), a myosin 2 inhibitor that impairs actin accumulation in the YSL, thereby delaying epibolic movements (Köppen et al., 2006). Notably, a 30 min treatment at 4hpf, was sufficient to delay epiboly progression − as quantified by the position of tbxta-positive margin cells (Figure 2E) − and to induce a short axis phenotype when treated animals reached 3dpf larval stage (Figure 2F). Notably, treatments at 3hpf or 5hpf did not result in such a short axis phenotype (Figure 2F).
Together these data support an association between a poor function of myosin 2, epiboly delay and shorter larval size. Nevertheless, factors other than myosin activation are likely contributing to the observed MZvgll4a phenotype, as calyculin-mediated over-activation of myosin did not rescue the body size of the mutant larvae (Supplementary Figure S3).
Maternal but not zygotic vgll4a contribution is necessary for a timely development
Many factors implicated in epiboly are maternally derived (Lepage and Bruce, 2010). The phenotype observed in MZvgll4a embryos was not observed in Zvgll4a mutant embryos obtained from heterozygous in-crosses (data not shown), suggesting that maternal but not zygotic vgll4a contributes to epiboly progression.
To test this possibility, we mated wt, heterozygous and mutant vgll4a fishes to generate larvae of different genotypes with or without vgll4a maternal contribution (Figures 3A, C). Determination of the body length of the resulting larvae showed that, similarly to MZvgll4a, Mvgll4a+/− embryos had an A-P axis shorter than that of vgll4a+/− and wt embryos (Figure 3B). This indicates that zygotic vgll4a cannot compensate for the lack of its maternal function. To demonstrate that maternal vgll4a is indeed sufficient, we crossed vgll4a mutant males with vgll4a heterozygous females and vgll4a heterozygous males with vgll4a mutant females to obtain Zvgll4a and MZvgll4a embryos, with or without maternal vgll4a contribution, respectively (Figure 3C). Notably, the body length of the resulting Zvgll4a larvae at 3dpf was very comparable to that of wt (Figure 3D), indicating that the observed developmental delay is linked exclusively to the absence of vgll4a maternal contribution.
FIGURE 3. Zygotic vgll4a function is dispensable for timely embryonic growth. (A,C) Schematic representation of the mating strategy used to obtain embryos of the desired genotypes with or without vgll4a maternal contribution. (B,D) Box plots of the body length from 3dpf larvae of the indicated genotypes. Note the decreased body length only in embryos with absent or haplo-insufficient maternal vgll4a contribution as compared to wt. The number of analyzed embryos is indicated below each plot. Data in B were analyzed with Kruskal–Wallis test, p < 0.0001, whereas those in D with One-Way ANOVA. ns, not significant. ***p < 0.001. ****p < 0.0001.
We next asked if vgll4b could have a similar maternally restricted function. MZvgll4b were significantly shorter than wt but the body length of Mvgll4b+/− larvae was comparable to that of wt (Supplementary Figure S4B), indicating that zygotic vgll4b compensates for its maternal function and that the MZvgll4b short axis phenotype is exclusively linked to the absence of vgll4b zygotic contribution (Supplementary Figure S4D).
To verify that the phenotype observed in MZvgll4a larvae is directly linked to the absence of the maternally inherited mRNA/protein, we sought to rescue MZvgll4a embryonic growth by injecting either the vgll4a-HA mRNA, its mutated version or the human VGLL4 protein in 1 cell stage embryos (Supplementary Figure S5A). None of the two mRNAs could rescue the growth of the mutant embryos (Supplementary Figure S5B), despite the presence of the HA-tagged protein in the blastomeres as determined by immunofluorescent staining (Supplementary Figures S5C, D). Injection of recombinant human VGLL4 protein instead partially rescued the growth of MZvgll4a embryos (Supplementary Figure S5E), likely because its immediate availability compensates for the maternal component.
Taken altogether, these observations demonstrate that maternal, but not zygotic, vgll4a is essential for timely embryonic development.
Vgll4a sustains Yap1 signaling to promote embryonic development
Vgll4 competes with Yap1 for TEAD binding in different biological contexts, thereby antagonizing its signaling (Koontz et al., 2013; Jiao et al., 2014; Zhang et al., 2014; Geng et al., 2021; Mickle et al., 2021; Cai et al., 2022). According to this mechanism, the MZvgll4a mutants should present an over-activation of Yap signaling and thus, Yap inhibition should rescue the MZvgll4a phenotype.
Direct testing of this possibility proved to be difficult as Western blot with three antibodies did not detect any of the Yap forms in lysates of 6hpf embryos. Furthermore, our attempt to cross the MZvgll4a line with the Yap/Taz-Tead responsive transgenic reporter line 4xGTIIC:eGFP (Miesfeld and Link, 2014) was unsuccessful, possibly explaining why in the original description positive signal was reported from 22hpf onward (Miesfeld and Link, 2014). To overcome these difficulties, we turned to pharmacological treatments.
Verteporfin acts as an efficient inhibitor of YAP-TEAD interaction, reducing Yap1 signaling in different models (Liu-Chittenden et al., 2012), including the zebrafish. We thus soaked normal (wt) and MZvgll4 embryos in this drug using a lower concentration (5uM) and shorter incubation times than those previously reported for older zebrafish embryos (Grampa et al., 2016; Fillatre et al., 2019) in order to prevent potential harmful effects in early stage embryos. We used the timeframe from one-cell stage to 75% epiboly, which is ideal to early maternal vgll4a activity. Embryos were let develop in fresh medium and their body length was measured at 3dpf (Figure 4A), finding that the A-P lengths of wt and MZvgll4l larvae was reduced (Figure 4B) as in MZvgll4a larvae (Figure 2B). Verteporfin instead had no effect on the A-P length of MZvgll4a and MZvgll4a;MZvgll4b larvae, which were undistinguishable from their respective untreated mates (Figure 4B). This suggests that in this scenario, vgll4a and yap1 functions do not compete one another but rather act in the same direction. To verify this possibility, we asked if yap signaling was decreased in MZvgll4a embryos, using the expression levels of the yap1 targets ccn1 and ccn2 as read-outs (Zhang et al., 2011). qPCR analysis showed that at sphere stage ccn1 transcripts in MZvgll4a embryos were significantly reduced compared to those of wt, although this difference was no longer evident at 75% epiboly stages (Figure 4C). The mRNAs of the related ccn2a and ccn2b were instead undetectable at these stages.
FIGURE 4. Vgll4a acts upstream of yap activity to promote embryonic growth. (A) Schematic representation of the experimental design in (B). (B) Box plots of the body length from wt, MZvgll4l, MZvgll4a and MZvgll4a;MZvgll4b embryos grown in the presence of verteporfin or DMSO. Note that the drug has no effect on the already reduced body length of MZvgll4a and MZvgll4a;MZvgll4b larvae but reduces that of wt and MZvgll4l larvae. T-test. wt, p < 0.0001; MZvgll4l, p = 0.0003; MZvgll4a, p = 0.5769 and MZvgll4a;MZvgll4b, p = 0.9744. (C) The graphs show the expression level of the Yap-TEAD transcriptional target ccn1 at sphere and 75% epiboly stage in wt and MZvgll4a embryos as determined by qRT-PCR analysis. Note the significant reduction of ccn1 expression in the mutants. T-test. At 4hpf, p = 0.0042 and at 8hpf, p = 0.0746. (D) Schematic representation of the experimental design of data reported in (E,F). (E) YAP mRNA injection rescues epiboly progression in MZvgll4a embryos to an extend similar to that of wt embryos whereas eGFP mRNA has no effect. Kruskal–Wallis test, p < 0.0001. wt vs. MZvgll4a mRNA YAP injected, p > 0.9999. (F) MZvgll4a embryos injected with YAP mRNA display a larvae body length larger than MZvgll4a embryos injected with control mRNA. One-Way ANOVA, p < 0.0001. Ns, not significant. **p < 0.01. ***p < 0.001. ****p < 0.0001.
These results suggest that maternal vgll4a function precedes yap activity. If this were the case, yap overexpression should rescue the phenotype of MZvgll4a embryos. To test this possibility, we first compared the ability of human YAP mRNA and of its constitutively active YAP-5SA version (Zhao et al., 2007) to activate Yap/Taz-Tead responsive transgenic reporter line 4xGTIIC:eGFP (Miesfeld and Link, 2014). Both mRNAs efficiently activated eGFP expression in the reporter line (Fig. S6A-M) but YAP-5SA mRNA induced morphologically evident malformations in 24 hpf embryos (Fig. S6N-P), indicating that continuous and uncontrolled pathway activation has harmful effects. Based on these results, we next injected only YAP mRNA in MZvgll4a embryos, which rescued their epibolic phenotype (Figures 4D, E) and partially rescued the A-P length of 3dpf larvae (Figure 4F).
Altogether these data indicate that maternal vgll4a is required to sustain yap1 signaling during zebrafish gastrulation.
Maternal vgll4a is required for constriction of the actomyosin ring during epiboly
Loss or knockdown of yap in medaka, zebrafish and Xenopus embryo causes a delay in blastopore closure (Gee et al., 2011; Porazinski et al., 2015). In the hir medaka fish yap mutant, this delay is associated with a reduced actomyosin-mediated tissue tension, as also observed after the combined knockdown of yap and taz in zebrafish (Porazinski et al., 2015). Furthermore, in hir mutants the expression of the yap signaling effector, arhgap18, which controls tissue tension, is downregulated (Porazinski et al., 2015).
We thus reasoned that if maternal vgll4a sustains Yap1 signaling, the MZvgll4a phenotype should be also associated with alterations of the actomyosin ring and a reduction of the epibolic arhgap18 expression. Indeed, in MZvgll4a embryos, the actomyosin ring was thinner (Figures 5A, B′, E) and the DEL and EVL margins were further apart than those of wt embryos (Figures 5A, B′, F). The contour of EVL cells close to the EVL margin was also irregular with evaginations that resembled lamellipodia structures and loss of cellular contacts (Figures 5C, D′). Furthermore, and similarly to the hir mutants, the transcript levels of arhgap18 were lower than those of wt (Figure 5G).
FIGURE 5. Maternal vgll4a is required for proper organization of the actomyosin ring. (A-D′) Confocal images of wt and MZvgll4a embryos at 75% epiboly stage (lateral views) stained with phalloidin and Hoechst to visualize F-actin and nuclei, respectively. Note that the actomyosin ring in MZvgll4a embryos is thinner (white brackets in A′, B′) and rather separated from the DEL margin (yellow arrows in A, B) as compared to wt embryos. Note also that F-actin distribution of EVL cells in MZvgll4a embryos is ruffled and disorganized (yellow arrowheads in D′) in contrast to the well aligned distribution in wt embryos. Asterisk in D, D′ indicates loss of cell-cell contacts. (E,F) Quantification of the actomyosin ring width and DEL-EVL distance in wt (n = 24) and MZvgll4a (n = 34) embryos. Mann-Whitney test, p < 0.0001). (G) The graphs show the expression level of arhgap18 transcripts in MZvgll4a and wt embryos at 75% epiboly stage. t-test, p = 0.041, as determined by qRT-PCR analysis. *, p < 0.05. ****, p < 0.0001. Scale Bars, a-b´ 50µm, c-d´, 20 µm.
Taken together these observations support the idea that vgll4a function is a requisite for yap1-dependent actomyosin ring contractility and thus epiboly progression.
Maternal vgll4a promotes E-cadherin/βcatenin distribution at the blastomere plasma membrane
Cells probe tension through plasma membrane proteins and then transmit the information to mechano-sensors such as Yap1 through cytoskeletal rearrangements (Dupont et al., 2011). Given that maternal vgll4a seemed to act upstream of yap1, we hypothesized that its activity could regulate blastomere adhesion and thus their tension probing capacity. Indeed in cancer cells, VGLL4 regulates the transcription of E-cadherin (Porazinski et al., 2015; Song et al., 2019) and the E-cadherin/α-Catenin/β-Catenin adhesion complex is an upstream regulator of Yap1 in different biological contexts (Kim et al., 2011; Schlegelmilch et al., 2011; Silvis et al., 2011). Furthermore, the epibolic phenotype of MZvgll4a embryos resembled that of the pou5fl/Oct4 deficient MZspg embryos (Lachnit et al., 2008; Song et al., 2013). In these mutants, deep cells move with a considerable delay in relation to the actin-depleted EVL margin, EVL cells form an abnormal number of lamellipodia (Lachnit et al., 2008, p. 2013; Song et al., 2013) and present a defective E-cadherin endosomal trafficking in blastomeres (Song et al., 2013). We thus compared the distribution of F-actin, β-catenin and E-Cadherin in wt and MZvgll4a embryos, as read outs of blastomere cohesion (Yap et al., 2018).
F-actin, β-catenin and, to a lesser extent, E-cadherin signal intensity of MZvgll4a EVL cells was significantly decreased at sphere stage (Figures 6A–H). These changes were less evident in DEL cells, where only β-catenin was significantly reduced at sphere (Supplementary Figures S6I-P) and shield (Supplementary Figure S7) stages. Nevertheless, the overall E-cadherin mRNA expression levels (cdh1) in wt and MZvgll4a embryos were similar at both sphere and shield stage (Supplementary Figures S8A, C). β-catenin acts as an effector of Wnt signaling and thus its decreased levels at the plasma membrane could be a consequence of an over-activation of the pathway. To test this possibility, we determined the expression levels of different Wnt targets and read-outs. No difference was observed in the levels of axin1, axin2 and lef1 expression between MZvgll4a and wt embryos at both sphere and shied stage (Supplementary Figure S8B, D).
FIGURE 6. Maternal vgll4a is required for plasma membrane localization of the E-cadherin/β-catenin complex. (A,I) Schematic representation of the different imaging strategies. (B-G; J-O) Confocal images of F-actin (B, E, J, M), β-catenin (C, F, K, N) and E-cadherin (D, G, L, O) distribution in EVL (B–G) and DEL (J–O) cells in wt and MZvgll4a embryos at sphere stage. Embryos were counterstained with Hoechst (nuclei, green). (H,P) The graphs depict the fluorescent signal intensity (in arbitrary units, a. u) for F-actin, β-catenin and E-cadherin in EVL (H) or DEL (P) cells of wt and MZvgll4a embryos. Mann Whitney test. (H) β-catenin, p = 0.0001, E-cadherin; p = 0.0425. (P) F-actin, p = 0.3154; β-catenin, p = 0.0006 and E-cadherin, p = 0.1599. Ns, not significant, *p < 0.05; ***p < 0.001; ****p < 0.0001. Scale bar, 10 µm.
All in all, these data indicate that maternal vgll4a promotes E-cadherin/β-catenin localization at the blastomeres’ plasma membrane and hence their actin cortex distribution.
Discussion
The genome of a fertilized egg is transcriptionally inactive. Thus, maternal RNAs and proteins present in the eggs are responsible for coordinating the first morphogenetic events that takes place during gastrulation, initially single-handed and then in cooperation with the progressively available zygotic gene products (Solnica-Krezel, 2020). In the zebrafish egg, these maternally derived molecules represent a large proportion of all possible gene products (Harvey et al., 2013). However, how many of them are critical for epiboly initiation and progression is still poorly defined. Genome wide (Kane et al., 1996) and specific maternal-effect mutational screens in zebrafish have identified only a limited number of mutants with an epibolic phenotype (Dosch et al., 2004; Wagner et al., 2004) and their subsequent characterization supports an important contribution of adhesion molecules and cytoskeletal components (Bruce, 2016). Other studies have thereafter identified a few maternally inherited transcriptional regulators, including eomes/tbr2, foxh1, pou5fl/oct4, nanog and yap1 (Bruce et al., 2005; Reim and Brand, 2006; Pei et al., 2007; Lachnit et al., 2008; Song et al., 2013; Porazinski et al., 2015; Gagnon et al., 2018; Veil et al., 2018). In this still fragmented scenario, our study adds a new component to the genetic network coordinating zebrafish epiboly, showing an important role for maternally inherited vgll4a, and, to some extent, for its paralog vgll4b. Notably, it also shows that vgll4a is required to support yap1 signalling and the expression of E-cadherin/β-catenin adhesion complex (directly or indirectly), thereby coordinating blastomere adhesion/cohesion. This observation aligns with recent studies demonstrating the versatility of Vgll4 in various biological contexts, extending beyond its established role as a Yap1 inhibitor (Fillatre et al., 2019; Xue et al., 2019; Quan et al., 2023; Wang et al., 2023).
Zebrafish epiboly can be divided in two phases: initiation or doming and progression. Our study underscore vgll4a requirement at doming with morphological consequences that become visible as epiboly progresses and later as the embryonic A-P axis extends. Our findings are substantiated by the distribution of tbxta, a marker for margin cells, at 4.5 and 8hpf. Additionally, disrupting myosin activity precisely at the 4hpf stage replicates the MZvgll4a mutant phenotype, both during epiboly and in larval stages. This observation establishes a functional link between these two events. A recent study strongly supports this possibility demonstrating reduced Xenopus A-P axis extension when tissue scale force production is wakened during gastrulation (Huebner et al., 2022). Furthermore, a short axis phenotype was also observed after interference with myosin activity in MZalkbh4 and Malkbh4 mutants (Sun et al., 2017), in which defective convergent extension movements were also reported. Thus, it is plausible that similar gastrulation defects may contribute to the phenotype observed in MZvgll4a embryos, although we have not investigated this possibility.
The large majority of factors implicated in doming are maternally expressed, as both vgll4a and vgll4b are (Xue et al., 2018). The time-lag between the postulated molecular activity of maternal vgll4a at doming and the phenotypic consequences about 4 hours later is also not surprising, as a similar delay has been reported for other factors contributing to epiboly initiation (Lachnit et al., 2008; Sun et al., 2017). A recent study has shown that at sphere stage the central blastula becomes “fluid” as a consequence of loss of cell-cell adhesion and increased cell division (Petridou et al., 2019). The blastoderm margins instead maintain cell-cell adhesion and thus tension thanks to the activity of wnt11 non-canonical signalling (Petridou et al., 2019), known to control E-cadherin availability at the plasma membrane (Ulrich et al., 2005). If this differential fluid vs. tense state is perturbed, the ability of the blastula to react to mechanical forces is altered and epiboly becomes defective (Petridou et al., 2019). In our experiments we have not detected changes in wnt signalling using the global expression of three different downstream targets. Furthermore, vgll4a role in epiboly seems to be strictly maternal (Solnica-Krezel, 2020) and thus could act upstream of wnt11 signalling. Vgll4a-mediated control of wnt signalling will impinge on E-cadherin/β-catenin availability at the plasma membrane and thereby on differential blastoderm viscosity that favours epiboly progression. In support of this possibility, vgll4 paralogs appear to control the expression of non-canonical wnt signaling components, including wnt11f2, fzd8a and fzd10 (Fillatre et al., 2019). Nonetheless, we cannot exclude that very local changes in wnt pathway activation may occur, thereby explaining the MZvgll4a mutants phenotype as proposed by Petridou et al. (Petridou et al., 2019). Alternatively, vgll4a could interfere with non-canonical wnt signaling indirectly through the regulation of wnt/β-catenin canonical pathway, as the two branches of the pathway can have antagonistic effects in morphogenesis (Cavodeassi et al., 2005). Indeed, VGLL4 seems to interfere with the formation of a TEAD4-TCF4 complex, which promotes cell proliferation in colorectal cancer (Jiao et al., 2017). Furthermore, VGLL4 overexpression suppresses nuclear β-catenin levels and inhibits migration and invasion of gastric cancer cells, while its inactivation has opposite effects (Li et al., 2015). As an additional possibility, vgll4a could directly regulate E-cadherin expression as observed in both gastric and breast cancers (Li et al., 2015; Song et al., 2019), thereby influencing the membrane levels of E-cadherin/β-catenin complexes. According to our data the latter possibilities are however less likely. We observed a small, although significant, decrease of E-cadherin membrane localization only in EVL cells of MZvgll4a embryos at sphere stage, and no significant changes in the mRNA levels of cdh1 or in those of three read-out of wnt/β-catenin signalling, but our analysis, performed with entire embryos, precludes the identification of changes present only in a small cell subset. Furthermore, we cannot rule out that the MZvgll4a phenotype might be associated with abnormal E-cadherin stability or trafficking, as reported for the zebrafish wnt11f2 and oct4/MZspg mutants (Song et al., 2013; Petridou et al., 2019). This destabilization, in turn, could impinge on the actin cortex, which seems incomplete in most EVL cells (Figure 6), and thereby on the integrity of tight junctions. Although we have not addressed this point, the morphology of the EVL layer in MZvgll4a mutants resembles that of embryos treated with the dynamin inhibitor Dynasore (Lepage et al., 2014) or that reported for E-Cadherin mutants (Lachnit et al., 2008).
We focused on vgll4a and report that the related vgll4l has no role in epiboly, consistent with its lack of early expression (Xue et al., 2018) and its suggested functional diversification (Fillatre et al., 2019). On the contrary, we show both vgll4a and vgll4b seem to be important for oocyte fecundity and that MZvgll4b and MZvgll4a mutants present a very comparable A-P axis phenotype. However, in contrast to what observed for vgll4a, maternal vgll4b activity can be compensated by its zygotic counterpart. Furthermore, MZvgll4a;MZvgll4b double mutants are phenotypically very comparable to the two single mutants, and the additional inactivation MZvgll4l does not significantly worsen the short axis phenotype, compatible with the absence of maternal vgll4l expression. This suggests that the different paralogs do not compensate each other function and that vgll4a and vgll4b perhaps act in a different spatio-temporal window that converges in the same shorter axis phenotype. At later stages of development, vgll4b has been implicated in erythropoiesis, terminal differentiation (Wang et al., 2020), heart valvulogenesis (Xue et al., 2019) and establishment of the left-right asymmetry in coordination with vgll4l (Fillatre et al., 2019). Our vgll4a mutants do not show similar traits, at least in a gross morphological analysis, further supporting a possible diversification of the paralogs’ activity.
Vgll4 has been initially described as co-transcriptional repressor that interacts with Tead transcription factors, thereby acting as an as antagonist of Yap signalling (Guo et al., 2013; Zhang et al., 2014). This function has been thereafter validated in multiple contexts especially in tumour development (Yamaguchi, 2020). Our study not only shows that maternal vgll4a is required for epiboly but also that does so supporting rather than antagonising Yap1 signalling. The generation of a transgenic Yap/Taz-Tead reporter zebrafish line faithfully highlights pathway activation from 22 hpf (Miesfeld and Link, 2014). Using this same line we have been unable to detect reporter expression at epiboly stages. However, we show that overexpression of YAP is sufficient to rescue the phenotype of MZvgll4a mutants, suggesting that, likely, maternal vgll4a acts upstream of Yap1, given that ccn1 expression is decreased in MZvgll4a mutants. Furthermore, addition of the Yap inhibitor verteporfin to wt embryos replicates the MZvgll4a phenotype but has no effect on the MZvgll4a mutants themselves.
Our analysis has been performed at the whole embryo scale, taking epiboly progression, actomyosin organization and cell cohesion as read-out of vgll4a function in morphogenetic rearrangement. These rearrangements highly depend on mechanical and biochemical events at the cellular and subcellular scale (Petridou et al., 2017; Stooke-Vaughan and Campàs, 2018). Therefore, in this scenario, we cannot exclude that the delay in epiboly progression observed in MZvgll4a embryos represents the macroscopic result of a series of mechano-chemical feedback loops at the cellular scale (Hannezo and Heisenberg, 2019), involving both vgll4a and yap1 in the same or even different cell populations.
Nevertheless, and independently of the relative position of vgll4a and yap1 in epiboly regulation, our data suggests that vgll4a may be required for a proper balance between tissue tension/cohesion and contractility, two factors that contribute to mechanical stress (Wozniak and Chen, 2009). Indeed, decreasing myosin contractility at doming mimics the absence of maternal vgll4a function. We thus hypothesis that in the absence of vgll4a, cellular cohesion mediated by adhesion complexes is poor, impairing embryonic mechano-sensation (Figure 7). This impairment would decrease yap-dependent mechano-transduction, which, in turn, could affect the contraction of the actomyosin network, delaying epiboly progression (Figure 7). In support of this model, the yap mechano-regulatory program seems to be essential for sustaining intracellular tension during gastrulation, that, in turn, controls the assembly of the embryonic A-P axis (Sousa-Ortega et al., 2023). Our simplified model does not take into account other and yet undetermined factors that contribute to this process. For example, we were unable to rescue the speed of epibolic movements in MZvgll4a embryos with calyculin, a drug that increases myosin 2 contractility, either because there are other compensatory mechanisms or because we have not chosen the appropriate time window.
FIGURE 7. Proposed model for maternal vgll4a contribution to zebrafish epiboly progression. Maternal vgll4a promotes plasma membrane localization of the E-cadherin/β-catenin complex in the amount required for an adequate cohesion among blastomeres. This cohesion threshold allows tissue mechano-sensing and thus yap1-dependent mechano-transduction. Signal transduction impacts on the organization and function of the actomyosin ring, thereby promoting timely epiboly progression. E-cad, E-cadherin; β-cat, β-catenin; F-act, F-actin.
Independently from these considerations and in a broader context, our data suggest that upregulation of vgll4 expression may serve to enhance the mechano-sensing properties of some tissues, perhaps restoring an unbalanced back-and-forth dialogue between biochemical and mechanical cues, which has been described in pathological conditions, including different type of primary and metastatic cancers (Deng and Fang, 2018).
Materials and methods
Maintenance of fish lines. Adult AB/TUE wild type, mutant (vgll4a, vgll4b, vgll4l) and 4xGTIIC:eGFP reporter line (Miesfeld and Link, 2014) zebrafish were maintained at 28°C on 14/10 h light/dark cycle. Embryos were raised at 28°C and staged according to the hours post fertilization (hpf) and their morphology. Embryos were growth in E3 medium (NaCl, 5 mM; KCl, 0.17 mM; CaCl2, 0.33 mM; MgSO4, 0.33 mM; 5.10% Methylene Blue). The ethical committee for Animal Experimentation of the Consejo Superior de Investigaciones Científicas (CSIC) and of the Comunidad Autónoma de Madrid approved the procedures used in the study.
Zebrafish mutants generation. Zebrafish mutant lines were generated using CRISPR/Cas9 technology. The gRNA were designed using the CHOP-CHOP tool (Labun et al., 2019) looking for potential disruption of enzyme restriction sites. gRNAs were synthesized using PCR templates as described in (Varshney et al., 2016). Cas9 protein (300 ng/μL; EnGen® Spy Cas9 NLS, New England Biolabs) and gRNAs (100 ng/μL; Table S1) were co-injected into one-cell stage zebrafish embryos. F0 embryos were raised and outcrossed with AB/TUE wt. PCR amplification on genomic DNA isolated from tail clips of F1 zebrafish embryos was performed to identify disruption of specific restriction sites (Table S2). The DNA of potential mutants was thereafter sequenced and the selected embryos were raised to adulthood. We selected mutants in which the reading frame was disrupted and truncated as follow: vgll4a-S85Mfs15, vgll4b-P156Rfs5 and vgll4l P111Hfs61 (see Supplementary Figure S1 for more details).
Embryo injections. Zebrafish embryos were injected at the 1 cell stage with 1 nL of the selected solutions using a IM-300/Narishige microinjector. Recombinant humanVGLL4 protein (0.19 ug/μL; Abnova, Ref: H00009686-P01) and vgll4a-HA mRNA (100 ng/μL) were used in rescue experiments. Phosphate buffer saline (PBS) containing 0.1% BSA or mutated vgll4a-HA mRNA (cloned from the vgll4a-S85Mfs15 line) were injected as controls. Myc-YAP, Myc-YAP-5SA and eGFP mRNAs were injected at 25 ng/ul.
Tissue processing and immunohistochemistry. Embryos were fixed by immersion in 4% paraformaldehyde in 0.1 M phosphate buffer pH 7.2 (wt/vol) overnight at 4 °C. Embryos were then washed in PBS with 0.5% Triton-X-100, incubated in a 15% sucrose-PBS solution (wt/vol), embedded and frozen in a 7.5% gelatin in 15% sucrose solution (wt/vol). Cryostat sections or whole embryos were stained using standard protocols and antibodies against the following antigens: HA (1:250, Sigma, H-6908), β-catenin (1:300, BD Bioscience, 610,154), E-cadherin (1:300, BD Bioscience, 610,181) and Yap (1:200, Cell Signaling Technology, #4912). Incubation with Phalloidin-TRITC (1:200, Sigma, P1951) was used to detect actin. Incubation with appropriate secondary antibodies was performed following standard procedures.
In situ hybridization (ISH). A specific tbtxa probe was generated by RT-PCR from cDNA of 6hpf embryos using the following primers (5′-GATCGGAAATATGTCTGC-3′ and 5′-GTTGTCAGTGCT GTGGTC-3′) with the Expand™ High Fidelity PCR System (Roche) and cloned with the StrataClone PCR Cloning Kit (Agilent). myod1 RNA probe was synthesized from cDNA encoding myod1 (Weinberg et al., 1996). Digoxigenin-UTP-labelled antisense riboprobes were synthesized in vitro using DIG RNA labelling Mix kit (Roche). Zebrafish embryos at different developmental stages were hybridized by standard procedures and visualized with NBT/BCIP (dark blue).
Construct generations. vgll4a was amplified from cDNA of wt or MZvgll4a (as control) embryos using the following primers (Fw: 5′-GGAATCAACAGTTAGCGTGCT-3’; Rv: 5′-aaCTCGAGTCAAGCGTAATCTGGAACATCGTATGGGTAAGACTGACCAACATGATTG-3′). The amplicon, includes the hemagglutinin (HA) epitope included in the reverse prime, was cloned by TA-cloning in the pSC-A vector using the StrataClone PCR Cloning Kit (Agilent). The vgll4a-HA fragment was thereafter liberated from the pCS-A construct using EcoRI/XhoI digestion and cloned in the pCS2 vector. The pCS2 construct, linearized with NotI, was used to synthesize mRNA from the wt or mutated vgll4a version, tagged with HA, using the mMESSAGE mMACHINE SP6 Transcription kit (Invitrogene) following manufacturer’s instructions. After transcription, mRNAs were purified using the NucleoSpin® RNA Clean-up kit (Machery Nagel). pQCXIH-Myc-YAP (Addgene plasmid # 33091) and pQCXIH-Myc-YAP-5SA (Addgene plasmid # 33093) (Zhao et al., 2007) were used to clone the Myc-tagged forms of human YAP in the pCS2 vector, after NotI (Takara) and EcoRI restriction digestion. The open pCS2 vector and the fragments were ligated using T4 DNA Ligase (NEB) and the resulting constructs used to synthesize the corresponding mRNA.
Quantitative RT-PCR analysis. Total RNA was isolated from wt and mutant embryos (n = 30, for each genotype) using TRIzol (Sigma) according to the manufacturer´s instruction. Each experiment was performed with biological triplicates. 5 μg of total RNA was used to synthesize the first-strand cDNA using the First-Strand cDNA synthesis kit (GE Healthcare) with a pd(N)6 primer. Each quantitative RT-qPCR reaction was performed using the GoTaq qPCR Master Mix kit (Promega). For a 10 µL reaction, 4 µL of cDNA (2.5 ng/μL) was mixed with 1 µL of primers (2.5 µM; Table S3) and 4 µL master mix. Reaction was incubated at 95°C for 10 min, then at 95°C for 15 s and 40 cycles and at 60°C for 60 s. The levels of the eef1a1l1 mRNA were used as housekeeping reference (Xu et al., 2016).
Pharmacological treatment. Embryos were incubated for different time-windows at 28°C in E3 medium containing appropriate volumes of DMSO alone or DMSO containing either Blebbistatin (203,390, Calbiochem) Calyculin A (BML-EI192, Enzo). or Verteporfin (5,305, Tocris). Treatment with 50 µM Blebbistatin was carried out for 30 min using three different time-windows (3, 4 and 5 hpf). Verteporfin (5 µM) was added to embryos at the 1 cell stage up to 75% epiboly (8 hpf). Calyculin A was used at four different concentrations (0.2 µM, 0.5 µM, 0.7µM and 1 µM) and added at 4hpf for 30 min.
Imaging. Sections were analysed with DM or confocal microscope. Zebrafish embryos at different stages were observed and photographed using a stereomicroscope and DFC500, DFC350 FX cameras (Leica Microsystems). For sections or whole embryo staining, LSM710 confocal laser scanning microscope coupled to an AxioObserver inverted microscope (Zeiss) were used to obtain digital images, which were then processed and analysed with ImageJ (Fiji) software. Images shown in Figure 1, Figure 4, Figure 5, Fig. S1, S4 and S6 were assembled using the Photoshop CS5 software.
Quantification and statistical analysis. All quantifications were performed using the ImageJ (Fiji) software. 72hpf embryonic larvae were treated with tricaine and photographed in lateral views at ×13 magnification to determine their body length. For epiboly progression quantifications, embryos hybridized with a tbxta probe were photographed and the total length of the egg and the distance between the margin cells and the vegetal pole were measured. Blastopore closure quantification was performed as previously reported (Köppen et al., 2006). The area of individual and centrally positioned blastoderm cells from wt and mutant embryos was determined by tracing their perimeter on confocal images of whole embryos stained with β-catenin antibody. Only one image per embryo was used. The position and width of the actomyosin ring was determined on z-stack files obtained from the confocal images of whole embryos. The z-stack files were used to generate maximum intensity projections. The mid-region of the actomyosin ring and DEL/EVL margins were positioned in the centre of the image to avoid possible visual distortions due to the embryo curvature and a rectangular region of interest (ROI) was selected covering the central area of the embryo. Ten different measurements of the width of the actomyosin ring as well as ten different measurements of the distance between DEL-EVL were obtained along the ROI using the “straight” selection tool. The ten measurement per embryo were averaged to obtain a more accurate value of the ring width and also the DEL-EVL distance and their means were used in the comparative analysis. Immunofluorescence intensity quantifications were performed using mid-plane of z-stack files obtained from the confocal imaging of β-catenin, F-actin and E-cadherin staining on whole embryos (EVL cells) or cryostat sections of different embryos (DEL cells). A rectangular ROI was used to measure the mean grey value of the selected image as indicator of signal intensity. GraphPad Prism 7 statistic software was used to analyze the data using t-test for two groups with parametric distribution and with Mann-Whitney test for two groups with no parametric distribution. One-way ANOVA test was used for more than two groups with parametric distribution with Tukey’s multiple comparisons test to analyze differences between groups. Kruskal–Wallis test for no parametric distribution with Dunn’s multiple comparisons test to analyze differences between groups. Fisher exact test was used in the analysis of Figure 1G. Statistical difference between pools of treated and control embryos was determined with the Pearson´s X2 test. Error bars indicate s. e.m. in all graphs.
Data availability statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.
Ethics statement
The animal study was approved by the Ethic Committe of the Consejo Superior de Investigacion Cientifica, CSIC. The study was conducted in accordance with the local legislation and institutional requirements.
Author contributions
CC-M: Conceptualization, Data curation, Formal Analysis, Investigation, Methodology, Visualization, Writing–original draft. NT: Investigation, Methodology, Visualization, Writing–original draft. ES-B: Investigation, Methodology, Visualization, Writing–original draft. PB: Conceptualization, Formal Analysis, Funding acquisition, Project administration, Resources, Supervision, Writing–review and editing. MC: Conceptualization, Data curation, Formal Analysis, Methodology, Supervision, Visualization, Writing–original draft.
Funding
The author(s) declare financial support was received for the research, authorship, and/or publication of this article. This work was supported by grants: PID2019-104186RB-I00; RED2018-102553-T; PID2022-136831OB-I00 and RED2022-134100-T funded by MCIN/AEI/ 10.13039/501100011033 and “ERDF A way of making Europe”. CCM was supported by a predoctoral contract from the CIBERER, whereas MJC by a Juan de la Cierva postdoctoral contract (IJCI-2016-27683) funded by MCIN/AEI/10.13039/501100011033. A CBM Institutional grant from the Fundación Ramon Areces is also acknowledged. The CBM is a Center of Excellence Severo Ochoa CEX2021-001154-S funded by MCIN/AEI/10.13039/501100011033.
Acknowledgments
We wish to acknowledge the excellent technical assistance of Alfonso Gutierrez Garcia in the fish facilities and the staff of the CBM Image analysis and Genomic facilities. We thank Joaquin Navajas Acedo for providing information about the wnt11f2 gene nomenclature and to B. Link for sharing the 4xGTIIC:eGFP line.
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fcell.2024.1362695/full#supplementary-material
References
Barrionuevo, M.-G., Aybar, M. J., and Tríbulo, C. (2014). Two different vestigial like 4 genes are differentially expressed during Xenopus laevis development. Int. J. Dev. Biol. 58, 369–377. doi:10.1387/ijdb.130353ct
Bruce, A. E. E. (2016). Zebrafish epiboly: spreading thin over the yolk. Dev. Dyn. 245, 244–258. doi:10.1002/dvdy.24353
Bruce, A. E. E., Howley, C., Dixon Fox, M., and Ho, R. K. (2005). T-box gene eomesodermin and the homeobox-containing Mix/Bix gene mtx2 regulate epiboly movements in the zebrafish. Dev. Dyn. 233, 105–114. doi:10.1002/dvdy.20305
Cai, J., Choi, K., Li, H., Pulgar Prieto, K. D., Zheng, Y., and Pan, D. (2022). YAP-VGLL4 antagonism defines the major physiological function of the Hippo signaling effector YAP. Genes Dev. 36, 1119–1128. doi:10.1101/gad.350127.122
Cavodeassi, F., Carreira-Barbosa, F., Young, R. M., Concha, M. L., Allende, M. L., Houart, C., et al. (2005). Early stages of zebrafish eye formation require the coordinated activity of Wnt11, Fz5, and the Wnt/beta-catenin pathway. Neuron 47, 43–56. doi:10.1016/j.neuron.2005.05.026
Deng, X., and Fang, L. (2018). VGLL4 is a transcriptional cofactor acting as a novel tumor suppressor via interacting with TEADs. Am. J. Cancer Res. 8, 932–943.
Dosch, R., Wagner, D. S., Mintzer, K. A., Runke, G., Wiemelt, A. P., and Mullins, M. C. (2004). Maternal control of vertebrate development before the midblastula transition: mutants from the zebrafish I. Dev. Cell 6, 771–780. doi:10.1016/j.devcel.2004.05.002
Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., et al. (2011). Role of YAP/TAZ in mechanotransduction. Nature 474, 179–183. doi:10.1038/nature10137
Faucheux, C., Naye, F., Tréguer, K., Fédou, S., Thiébaud, P., and Théze, N. (2010). Vestigial like gene family expression in Xenopus: common and divergent features with other vertebrates. Int. J. Dev. Biol. 54, 1375–1382. doi:10.1387/ijdb.103080cf
Feng, X., Wang, Z., Wang, F., Lu, T., Xu, J., Ma, X., et al. (2019). Dual function of VGLL4 in muscle regeneration. EMBO J. 38, e101051. doi:10.15252/embj.2018101051
Fillatre, J., Fauny, J.-D., Fels, J. A., Li, C., Goll, M., Thisse, C., et al. (2019). TEADs, Yap, Taz, Vgll4s transcription factors control the establishment of Left-Right asymmetry in zebrafish. Elife 8, e45241. doi:10.7554/eLife.45241
Gagnon, J. A., Obbad, K., and Schier, A. F. (2018). The primary role of zebrafish nanog is in extra-embryonic tissue. Development 145, dev147793. doi:10.1242/dev.147793
Gee, S. T., Milgram, S. L., Kramer, K. L., Conlon, F. L., and Moody, S. A. (2011). Yes-associated protein 65 (YAP) expands neural progenitors and regulates Pax3 expression in the neural plate border zone. PLoS One 6, e20309. doi:10.1371/journal.pone.0020309
Geng, H., Liu, G., Hu, J., Li, J., Wang, D., Zou, S., et al. (2021). HOXB13 suppresses proliferation, migration and invasion, and promotes apoptosis of gastric cancer cells through transcriptional activation of VGLL4 to inhibit the involvement of TEAD4 in the Hippo signaling pathway. Mol. Med. Rep. 24, 722. doi:10.3892/mmr.2021.12361
Grampa, V., Delous, M., Zaidan, M., Odye, G., Thomas, S., Elkhartoufi, N., et al. (2016). Novel NEK8 mutations cause severe syndromic renal cystic dysplasia through YAP dysregulation. PLoS Genet. 12, e1005894. doi:10.1371/journal.pgen.1005894
Guo, T., Lu, Y., Li, P., Yin, M.-X., Lv, D., Zhang, W., et al. (2013). A novel partner of Scalloped regulates Hippo signaling via antagonizing Scalloped-Yorkie activity. Cell Res. 23, 1201–1214. doi:10.1038/cr.2013.120
Hannezo, E., and Heisenberg, C.-P. (2019). Mechanochemical feedback loops in development and disease. Cell 178, 12–25. doi:10.1016/j.cell.2019.05.052
Harvey, S. A., Sealy, I., Kettleborough, R., Fenyes, F., White, R., Stemple, D., et al. (2013). Identification of the zebrafish maternal and paternal transcriptomes. Development 140, 2703–2710. doi:10.1242/dev.095091
Hu, J., Sun, S., Jiang, Q., Sun, S., Wang, W., Gui, Y., et al. (2013). Yes-associated protein (yap) is required for early embryonic development in zebrafish (Danio rerio). Int. J. Biol. Sci. 9, 267–278. doi:10.7150/ijbs.4887
Huebner, R. J., Weng, S., Lee, C., Sarıkaya, S., Papoulas, O., Cox, R. M., et al. (2022). ARVCF catenin controls force production during vertebrate convergent extension. Dev. Cell 57, 1119–1131.e5. doi:10.1016/j.devcel.2022.04.001
Jiao, S., Li, C., Hao, Q., Miao, H., Zhang, L., Li, L., et al. (2017). VGLL4 targets a TCF4-TEAD4 complex to coregulate Wnt and Hippo signalling in colorectal cancer. Nat. Commun. 8, 14058. doi:10.1038/ncomms14058
Jiao, S., Wang, H., Shi, Z., Dong, A., Zhang, W., Song, X., et al. (2014). A peptide mimicking VGLL4 function acts as a YAP antagonist therapy against gastric cancer. Cancer Cell 25, 166–180. doi:10.1016/j.ccr.2014.01.010
Kane, D. A., Hammerschmidt, M., Mullins, M. C., Maischein, H. M., Brand, M., van Eeden, F. J., et al. (1996). The zebrafish epiboly mutants. Development 123, 47–55. doi:10.1242/dev.123.1.47
Kim, N.-G., Koh, E., Chen, X., and Gumbiner, B. M. (2011). E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc. Natl. Acad. Sci. U. S. A. 108, 11930–11935. doi:10.1073/pnas.1103345108
Kimmel, C. B., Ballard, W. W., Kimmel, S. R., Ullmann, B., and Schilling, T. F. (1995). Stages of embryonic development of the zebrafish. Dev. Dyn. 203, 253–310. doi:10.1002/aja.1002030302
Koontz, L. M., Liu-Chittenden, Y., Yin, F., Zheng, Y., Yu, J., Huang, B., et al. (2013). The Hippo effector Yorkie controls normal tissue growth by antagonizing scalloped-mediated default repression. Dev. Cell 25, 388–401. doi:10.1016/j.devcel.2013.04.021
Köppen, M., Fernández, B. G., Carvalho, L., Jacinto, A., and Heisenberg, C.-P. (2006). Coordinated cell-shape changes control epithelial movement in zebrafish and Drosophila. Development 133, 2671–2681. doi:10.1242/dev.02439
Labun, K., Montague, T. G., Krause, M., Torres Cleuren, Y. N., Tjeldnes, H., and Valen, E. (2019). CHOPCHOP v3: expanding the CRISPR web toolbox beyond genome editing. Nucleic Acids Res. 47, W171–W174. doi:10.1093/nar/gkz365
Lachnit, M., Kur, E., and Driever, W. (2008). Alterations of the cytoskeleton in all three embryonic lineages contribute to the epiboly defect of Pou5f1/Oct4 deficient MZspg zebrafish embryos. Dev. Biol. 315, 1–17. doi:10.1016/j.ydbio.2007.10.008
Lepage, S. E., and Bruce, A. E. E. (2010). Zebrafish epiboly: mechanics and mechanisms. Int. J. Dev. Biol. 54, 1213–1228. doi:10.1387/ijdb.093028sl
Lepage, S. E., Tada, M., and Bruce, A. E. E. (2014). Zebrafish Dynamin is required for maintenance of enveloping layer integrity and the progression of epiboly. Dev. Biol. 385, 52–66. doi:10.1016/j.ydbio.2013.10.015
Li, F., Liu, R., Negi, V., Yang, P., Lee, J., Jagannathan, R., et al. (2023). VGLL4 and MENIN function as TEAD1 corepressors to block pancreatic β cell proliferation. Cell Rep. 42, 111904. doi:10.1016/j.celrep.2022.111904
Li, H., Wang, Z., Zhang, W., Qian, K., Liao, G., Xu, W., et al. (2015). VGLL4 inhibits EMT in part through suppressing Wnt/β-catenin signaling pathway in gastric cancer. Med. Oncol. 32, 83. doi:10.1007/s12032-015-0539-5
Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S.-J., Anders, R. A., et al. (2012). Genetic and pharmacological disruption of the TEAD-YAP complex suppresses the oncogenic activity of YAP. Genes Dev. 26, 1300–1305. doi:10.1101/gad.192856.112
Mickle, M., Adhikary, G., Shrestha, S., Xu, W., and Eckert, R. L. (2021). VGLL4 inhibits YAP1/TEAD signaling to suppress the epidermal squamous cell carcinoma cancer phenotype. Mol. Carcinog. 60, 497–507. doi:10.1002/mc.23307
Miesfeld, J. B., and Link, B. A. (2014). Establishment of transgenic lines to monitor and manipulate Yap/Taz-Tead activity in zebrafish reveals both evolutionarily conserved and divergent functions of the Hippo pathway. Mech. Dev. 133, 177–188. doi:10.1016/j.mod.2014.02.003
Panciera, T., Azzolin, L., Cordenonsi, M., and Piccolo, S. (2017). Mechanobiology of YAP and TAZ in physiology and disease. Nat. Rev. Mol. Cell Biol. 18, 758–770. doi:10.1038/nrm.2017.87
Pei, W., Noushmehr, H., Costa, J., Ouspenskaia, M. V., Elkahloun, A. G., and Feldman, B. (2007). An early requirement for maternal FoxH1 during zebrafish gastrulation. Dev. Biol. 310, 10–22. doi:10.1016/j.ydbio.2007.07.011
Petridou, N. I., Grigolon, S., Salbreux, G., Hannezo, E., and Heisenberg, C.-P. (2019). Fluidization-mediated tissue spreading by mitotic cell rounding and non-canonical Wnt signalling. Nat. Cell Biol. 21, 169–178. doi:10.1038/s41556-018-0247-4
Petridou, N. I., Spiró, Z., and Heisenberg, C.-P. (2017). Multiscale force sensing in development. Nat. Cell Biol. 19, 581–588. doi:10.1038/ncb3524
Porazinski, S., Wang, H., Asaoka, Y., Behrndt, M., Miyamoto, T., Morita, H., et al. (2015). YAP is essential for tissue tension to ensure vertebrate 3D body shape. Nature 521, 217–221. doi:10.1038/nature14215
Quan, Y., Hu, M., Jiang, J., Jin, P., Fan, J., Li, M., et al. (2023). VGLL4 promotes vascular endothelium specification via TEAD1 in the vascular organoids and human pluripotent stem cells-derived endothelium model. Cell Mol. Life Sci. 80, 215. doi:10.1007/s00018-023-04858-w
Reim, G., and Brand, M. (2006). Maternal control of vertebrate dorsoventral axis formation and epiboly by the POU domain protein Spg/Pou2/Oct4. Development 133, 2757–2770. doi:10.1242/dev.02391
Schlegelmilch, K., Mohseni, M., Kirak, O., Pruszak, J., Rodriguez, J. R., Zhou, D., et al. (2011). Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell 144, 782–795. doi:10.1016/j.cell.2011.02.031
Sheldon, C., Farley, A., Ma, Q., Pu, W. T., and Lin, Z. (2022). Depletion of VGLL4 causes perinatal lethality without affecting myocardial development. Cells 11, 2832. doi:10.3390/cells11182832
Silvis, M. R., Kreger, B. T., Lien, W.-H., Klezovitch, O., Rudakova, G. M., Camargo, F. D., et al. (2011). α-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Sci. Signal 4, ra33. doi:10.1126/scisignal.2001823
Solnica-Krezel, L. (2020). “Chapter Thirteen - maternal contributions to gastrulation in zebrafish,” in Current topics in developmental Biology, maternal effect genes in development. Editor F. L. Marlow (Cambridge, Massachusetts: Academic Press), 391–427. doi:10.1016/bs.ctdb.2020.05.001
Song, H., Luo, Q., Deng, X., Ji, C., Li, D., Munankarmy, A., et al. (2019). VGLL4 interacts with STAT3 to function as a tumor suppressor in triple-negative breast cancer. Exp. Mol. Med. 51, 1–13. doi:10.1038/s12276-019-0338-8
Song, S., Eckerle, S., Onichtchouk, D., Marrs, J. A., Nitschke, R., and Driever, W. (2013). Pou5f1-dependent EGF expression controls E-cadherin endocytosis, cell adhesion, and zebrafish epiboly movements. Dev. Cell 24, 486–501. doi:10.1016/j.devcel.2013.01.016
Sousa-Ortega, A., Vázquez-Marín, J., Sanabria-Reinoso, E., Corbacho, J., Polvillo, R., Campoy-López, A., et al. (2023). A Yap-dependent mechanoregulatory program sustains cell migration for embryo axis assembly. Nat. Commun. 14, 2804. doi:10.1038/s41467-023-38482-w
Stooke-Vaughan, G. A., and Campàs, O. (2018). Physical control of tissue morphogenesis across scales. Curr. Opin. Genet. Dev. 51, 111–119. doi:10.1016/j.gde.2018.09.002
Sun, Q., Liu, X., Gong, B., Wu, D., Meng, A., and Jia, S. (2017). Alkbh4 and atrn act maternally to regulate zebrafish epiboly. Int. J. Biol. Sci. 13, 1051–1066. doi:10.7150/ijbs.19203
Suo, J., Feng, X., Li, J., Wang, J., Wang, Z., Zhang, L., et al. (2020). VGLL4 promotes osteoblast differentiation by antagonizing TEADs-inhibited Runx2 transcription. Sci. Adv. 6, eaba4147. doi:10.1126/sciadv.aba4147
Sztal, T. E., and Stainier, D. Y. R. (2020). Transcriptional adaptation: a mechanism underlying genetic robustness. Development 147, dev186452. doi:10.1242/dev.186452
Ulrich, F., Krieg, M., Schötz, E.-M., Link, V., Castanon, I., Schnabel, V., et al. (2005). Wnt11 functions in gastrulation by controlling cell cohesion through Rab5c and E-cadherin. Dev. Cell 9, 555–564. doi:10.1016/j.devcel.2005.08.011
Varshney, G. K., Carrington, B., Pei, W., Bishop, K., Chen, Z., Fan, C., et al. (2016). A high-throughput functional genomics workflow based on CRISPR/Cas9-mediated targeted mutagenesis in zebrafish. Nat. Protoc. 11, 2357–2375. doi:10.1038/nprot.2016.141
Vázquez-Marín, J., Gutiérrez-Triana, J. A., Almuedo-Castillo, M., Buono, L., Gómez-Skarmeta, J. L., Mateo, J. L., et al. (2019). Yap1b, a divergent Yap/Taz family member, cooperates with yap1 in survival and morphogenesis via common transcriptional targets. Dev. Dev. 146, 173286. doi:10.1242/dev.173286
Veil, M., Schaechtle, M. A., Gao, M., Kirner, V., Buryanova, L., Grethen, R., et al. (2018). Maternal Nanog is required for zebrafish embryo architecture and for cell viability during gastrulation. Development 145, dev155366. doi:10.1242/dev.155366
Wagner, D. S., Dosch, R., Mintzer, K. A., Wiemelt, A. P., and Mullins, M. C. (2004). Maternal control of development at the midblastula transition and beyond: mutants from the zebrafish II. Dev. Cell 6, 781–790. doi:10.1016/j.devcel.2004.04.001
Wang, Y., Liu, X., Xie, B., Yuan, H., Zhang, Y., and Zhu, J. (2020). The NOTCH1-dependent HIF1α/VGLL4/IRF2BP2 oxygen sensing pathway triggers erythropoiesis terminal differentiation. Redox Biol. 28, 101313. doi:10.1016/j.redox.2019.101313
Wang, Z., Quan, Y., Hu, M., Xu, Y., Chen, Y., Jin, P., et al. (2023). VGLL4-TEAD1 promotes vascular smooth muscle cell differentiation from human pluripotent stem cells via TET2. J. Mol. Cell Cardiol. 176, 21–32. doi:10.1016/j.yjmcc.2023.01.005
Warga, R. M., and Kimmel, C. B. (1990). Cell movements during epiboly and gastrulation in zebrafish. Development 108, 569–580. doi:10.1242/dev.108.4.569
Weinberg, E. S., Allende, M. L., Kelly, C. S., Abdelhamid, A., Murakami, T., Andermann, P., et al. (1996). Developmental regulation of zebrafish MyoD in wild-type, no tail and spadetail embryos. Development 122, 271–280. doi:10.1242/dev.122.1.271
Wozniak, M. A., and Chen, C. S. (2009). Mechanotransduction in development: a growing role for contractility. Nat. Rev. Mol. Cell Biol. 10, 34–43. doi:10.1038/nrm2592
Xu, H., Li, C., Zeng, Q., Agrawal, I., Zhu, X., and Gong, Z. (2016). Genome-wide identification of suitable zebrafish Danio rerio reference genes for normalization of gene expression data by RT-qPCR. J. Fish. Biol. 88, 2095–2110. doi:10.1111/jfb.12915
Xue, C., Liu, X., Wen, B., Yang, R., Gao, S., Tao, J., et al. (2019). Zebrafish vestigial like family member 4b is required for valvulogenesis through sequestration of transcription factor myocyte enhancer factor 2c. Front. Cell Dev. Biol. 7, 277. doi:10.3389/fcell.2019.00277
Xue, C., Wang, H. H., Zhu, J., and Zhou, J. (2018). The expression patterns of vestigial like family member 4 genes in zebrafish embryogenesis. Gene Expr. Patterns 28, 34–41. doi:10.1016/j.gep.2018.02.001
Yamaguchi, N. (2020). Multiple roles of vestigial-like family members in tumor development. Front. Oncol. 10, 1266. doi:10.3389/fonc.2020.01266
Yang, W., Wang, Y., Jiang, D., Tian, C., Zhu, C., Li, G., et al. (2020). ddRADseq-assisted construction of a high-density SNP genetic map and QTL fine mapping for growth-related traits in the spotted scat (Scatophagus argus). BMC Genomics 21, 278. doi:10.1186/s12864-020-6658-1
Yap, A. S., Duszyc, K., and Viasnoff, V. (2018). Mechanosensing and mechanotransduction at cell-cell junctions. Cold Spring Harb. Perspect. Biol. 10, a028761. doi:10.1101/cshperspect.a028761
Zhang, H., Pasolli, H. A., and Fuchs, E. (2011). Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin. Proc. Natl. Acad. Sci. U. S. A. 108, 2270–2275. doi:10.1073/pnas.1019603108
Zhang, W., Gao, Y., Li, P., Shi, Z., Guo, T., Li, F., et al. (2014). VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex. Cell Res. 24, 331–343. doi:10.1038/cr.2014.10
Keywords: YAP signaling, VGLL4, vgll4a, actomyosin, E-cadherin complex, epiboly
Citation: Camacho-Macorra C, Tabanera N, Sánchez-Bustamante E, Bovolenta P and Cardozo MJ (2024) Maternal vgll4a regulates zebrafish epiboly through Yap1 activity. Front. Cell Dev. Biol. 12:1362695. doi: 10.3389/fcell.2024.1362695
Received: 28 December 2023; Accepted: 01 February 2024;
Published: 20 February 2024.
Edited by:
James Alan Marrs, Purdue University Indianapolis, United StatesReviewed by:
Yonggang Zheng, University of Texas Southwestern Medical Center, United StatesPatrizia Romani, University of Padua, Italy
Copyright © 2024 Camacho-Macorra, Tabanera, Sánchez-Bustamante, Bovolenta and Cardozo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Paola Bovolenta, pbovolenta@cbm.csic.es
†Present Address: Dept Genetics, University of Cambridge, Cambridge, United Kingdom
‡These authors share last authorship